Summary
64 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 12 USD is left as net profit.
- It has raised its dividend 20 years in a row.
- It earns 12 USD a year on every 100 USD of invested capital.
What to watch
- Revenue fell by 5.1% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- Analysts expect revenue to fall by 3.6% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 18.7 USD for 1 USD of yearly profit. Over the last five years it was 21.6 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 2.1% a year over 5 years. Over the last 3 years it fell by 5.1% a year. For the next fiscal year analysts expect revenue to fall by 3.6%. Earnings per share grew by 2.0% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 63 USD
- Sales and administration 24 USD
- Taxes and other 0.6 USD
- Net profit 12 USD
Net profit, industry median (Household & Personal Products) 9.4 USD
Out of every 100 USD of revenue, 12 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 2.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 4.64%
- Paid out of profit
- 87%
- Raised in a row
- 20 years
You receive $5.10 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 9
- Hold 20
- Sell 3
Today's price within the analysts' price targets
The average target of $114.8 is 6.4% above today's price. 28% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Diapers 41%
- Consumer tissue products 25%
- Adult care products 12%
- Away from Home Professional Products 11%
- Feminine care products 10%
By region
- UNITED STATES 100%
Diapers brings in 41% of revenue.
Segments in detail